Table 1. Baseline Characteristics of Studied Patients.
| Characteristic | SVR (n = 44) | non-SVR (n = 16) | P value |
| Gender (Male/Female) | 26/18 | 9/7 | NS† |
| Age (yrs) | 56 (22–72)* | 59 (30–80) | 0.04‡ |
| BMI | 23.5 (16.6–30.3) | 24.7 (18.5–31.7) | NS‡ |
| ALT (IU/l) | 51 (19–380) | 41 (17–390) | NS‡ |
| GGTP (IU/l) | 36 (11–133) | 40 (17–292) | NS‡ |
| T.Chol (mg/dl) | 169 (119–225) | 178 (145–217) | NS‡ |
| WBC (/µl) | 4600 (2620–7200) | 5080 (3270–8600) | NS‡ |
| Hb (g/dl) | 14.2 (11.5–17.3) | 14.6 (11.8–16.4) | NS‡ |
| Platelet (×104/mm3) | 19 (7.1–31.8) | 17.8 (8–36.7) | NS‡ |
| Fibrosis score (0–2/≥3)§ | 38/5 | 7/3 | NS† |
| HCV RNA (KIU/ml) | 2050 (100–16000) | 1800 (140–6300) | NS‡ |
| IFN dose (≥80%/60–80%) | 36/8 | 13/3 | NS† |
| Ribavirin dose (≥80%/60–80%) | 32/12 | 10/6 | NS† |
| RVR rate (%) | 55.8 | 6.3 | 0.0008† |
| EVR rate (%) | 97.7 | 68.8 | 0.004† |
| ETR rate (%) | 100 | 87.5 | NS† |
§: SVR : n = 43, non-SVR : n = 10.
*: median (range).
†: Fisher's exact probability test.
‡: Mann-Whitney's U test.